Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CA.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.83NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.2.4 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.161NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.58NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.75NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.411NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.217NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.17 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.527NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.500NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.147NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.487NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.121NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AA.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AS.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.115NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.127.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.422NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.56NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.4.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.198NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.366NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.441NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.416NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.263NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.135NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.219NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.208NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.125.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.78 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.159NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.5 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used